| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 143,422 | 144,374 | 157,604 | 193,645 | | Cost of Revenue | 102,644 | 102,990 | 111,530 | 136,729 | | | Gross Profit | 40,778 | 41,384 | 46,074 | 56,916 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 35,145 | 36,263 | 39,382 | 43,568 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,633 | 5,121 | 6,692 | 13,348 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9 | 48 | 14 | 116 | | Earnings Before Interest And Taxes | 5,642 | 5,169 | 6,706 | 13,464 | | Interest Expense | 1,232 | 1,335 | 1,453 | 2,115 | | Income Before Tax | 4,410 | 3,834 | 5,253 | 11,349 | | Income Tax Expense | 1,726 | 1,668 | 2,081 | 4,300 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,684 | 2,166 | 3,172 | 7,049 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,684 | 2,166 | 3,172 | 7,049 | | Preferred Stock And Other Adjustments | (22) | (23) | (15) | (22) | | | Net Income Applicable To Common Shares | $2,662 | $2,143 | $3,157 | $7,027 |
|
0.26% Nasdaq 
Income Statement
